Why did domestic companies join in ADA to announce their new antidiabetics?

With study results of antidiabetics that are being developed with foreign pharmaceutical companies, domestic companies started to knock the door of the American Diabetes Association(ADA).

Domestic new drugs represented at the ADA are: 3 new biomedicines that are being developed by Hanmi Pharm(efpeglenatide, LAPSInsulin115, LAPSGLP/GCG(HM12525A)), the Samsung Bioepis’s Lantus biosimilar(SB-9/MS...